Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $309.16 USD
Change Today +2.35 / 0.77%
Volume 2.0M
As of 8:04 PM 06/1/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

Morris Corporate Center III

400 Interpace Parkway

Parsippany, NJ 07054

United States

Phone: 862-261-7000

Fax:

olesalers, mail order, government and national retail drug and food store chains utilizing a small team of sales and marketing professionals. During 2014, on a combined business, the company expanded its generic product line with the launch of approximately 550 generic products worldwide. Strategy: The company’s strategy in the U.S. is to develop pharmaceuticals that are difficult to formulate or manufacture or would complement or broaden its existing product lines. Anda Distribution This segment distributes generic and brand pharmaceutical products manufactured by third parties, as well as by the company, primarily to independent pharmacies, pharmacy chains, pharmacy buying groups, and physicians’ offices. Sales are principally generated through the company’s national accounts relationships, an in-house telemarketing staff and through internally developed ordering systems. Additionally, the company sells to members of buying groups, which are independent pharmacies that join together to improve their buying power. The company also distributes its own products and collaborative partners’ products. This segment distributes products for approximately 340 suppliers and is focused on providing next-day delivery and responsive service to its customers. As of December 31, 2014, the company distributed approximately 12,650 stock-keeping units through its Anda Distribution segment. Customers In the company’s North American Brands and North American Generics and International operations, the company sells its generic and brand pharmaceutical products primarily to drug wholesalers, retailers, and distributors, including national retail drug and food store chains, hospitals, clinics, mail order retailers, government agencies, and managed healthcare providers, such as health maintenance organizations and other institutions. In the company’s Anda Distribution business, the company distributes generic and brand pharmaceutical products to independent pharmacies, alternate care providers (hospitals, nursing homes, and mail order pharmacies), pharmacy chains, physicians’ offices, and buying groups. The company’s customers include AmerisourceBergen Corporation; McKesson Corporation; Cardinal Healthcare, Inc.; and Walgreens. Acquisitions In July 2014, the company completed an agreement to acquire Furiex Pharmaceuticals, Inc. In April 2014, the company acquired Silom Medical Company, a privately held generic pharmaceutical company focused on developing and marketing therapies in Thailand. Business Strategy The company applies three major strategies to achieve growth for its North American Brands, and North American Generics and International businesses, such as internal development of differentiated and high-demand products, including in certain circumstances as it relates to generics, requiring patents associated with these products; the establishment of strategic alliances and collaborations; and the acquisition of products and companies that complement its business. Government Regulation and Regulatory Matters The company is subject to extensive, complex, and evolving regulation by the federal government, principally the U.S. Food and Drug Administration, and to a lesser extent, by the U.S. Drug Enforcement Administration, Occupational Safety and Health Administration, and state government agencies, as well as by various regulatory agencies in foreign countries where its products or product candidates are being manufactured and/or marketed. The Federal Food, Drug and Cosmetic Act; the Controlled Substances Act; and other federal statutes and regulations govern or influence the testing, manufacturing, packing, labeling, storing, record keeping, safety, approval, advertising, promotion, sale, and distribution of the company’s products. Competition The company’s major competitors include Teva Pharmaceutical Industries, Ltd.; Mylan Inc.; and Sandoz, Inc. (a division of Novartis AG). In its Anda Distribution segment, the company competes with McKesson Corporation, AmerisourceBergen Corporation, and Cardinal Health, Inc.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACT:US $309.16 USD +2.35

ACT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bristol-Myers Squibb Co $66.48 USD +1.88
GlaxoSmithKline PLC 1,446 GBp -10.00
Medtronic PLC $76.70 USD +0.38
Novo Nordisk A/S kr387.10 DKK -2.00
Valeant Pharmaceuticals International Inc C$300.08 CAD +3.64
View Industry Companies
 

Industry Analysis

ACT

Industry Average

Valuation ACT Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 6.1x
Price/Book 1.8x
Price/Cash Flow 140.2x
TEV/Sales 4.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACTAVIS PLC, please visit www.actavis.ie. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.